Nanomedicine-an overview

International Journal of PharmTech Research

Volumn 2, Issue 4, 2010, Pages 2143-2151

  Bhowmik, Debjit ^a   Chiranjib, ^a   Margret Chandira, R ^a   Tripathi, K K ^a   Sampath Kumar, K P ^b  

^a Rajeev Gandhi College of Pharmacy   (India)

^b Department of Microbiology   (India)

Author keywords

Nanomedicine

Indexed keywords

ANTIBIOTIC AGENT; BIOMIMETIC MATERIAL; DOXORUBICIN; NANOPARTICLE; SILVER NANOPARTICLE;

ALZHEIMER DISEASE; ANTIBIOTIC RESISTANCE; BIOMIMETICS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CELL PROLIFERATION; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; HEALTH CARE; HUMAN; IN VIVO STUDY; NANOENGINEERING; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; PHARMACOGENETICS; RETROLENTAL FIBROPLASIA; REVIEW; ROBOTICS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 78349257831     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Iijima S. Helicle microtubule of graphite carbon. Nature. 1991; 354: 56-58.
2. Tomalia D. A. Dendrimer as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichimica Acta. 2004; 37(2): 39-57.
3. Edward P. T. and Michele M. S. Application of nanotechnology: A case study in the pharmaceutical area. 2004. http://www.foley.com
4. Merisko-Liversidge E., Liversidge G. G., and Cooper E. R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003; 18(2): 113-120.
5. Liversidge G. G., Cundy K. C., Bishop J. and Czekai, D. Surface modified Drug Nanoparticles. US patent 5, 145, 684. 1992.
6. Müller R. H. and Böhm B. H. L. Nanosuspensions In: Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs. Müller R. H., Benita S., Böhm B. H. L., eds. Stuttgart, Germany: Medpharm Scientific Publishers; 1998:153.
7. Müller R. H., Jacobs C., and Kayser, O. Nanosuspensions as particulate drug formulations in therapy: rational for drug development and what can we expect for the future. Adv. Drug Deliv. Rev. 2001; 47(1): 3-19.
8. Krause K. P., and Müller R. H. Production and characterization of highly concentrated nanosupensions by high pressure homogenization. Int. J. Pharm. 2001; 214(1-2): 21-24.
9. Lopez-Quintela M. A. and Rivas J. J Colloid Interface Sci. 1993; 158: 446-451.
10. Williams R. O. et al. Process for production of nanoparticles and microparticles by spray freezing in to liquid. US Patent 6862890 (2005).
11. Rogers T. L., Nelson A. C., Sakari M., Young T. J., Johnston K. P., and Williams R. O. Enhanced aqueous dissolution of a poorly water-soluble by novel particle engineering technology: spray freezing in to liquid with atmospheric freeze-drying. Pharm. Res. 2003; 20(3): 485-493.
12. Hu J., Johnston K. P., and Williams R. O. Rapid dissolving high potency danazol powder produced by spray-freezing into liquid process. Int J Pharm. 2004; 271: 145-154.
13. Chen X., Young T. J., Sarkari M., Williams R. O. and Johnston K. P. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm. 2002; 242(1-2): 3-14.
14. Young T. J., Johnston K. P., Mishima K., and Tanaka H. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapour over liquid antisolvent. J. Pharm. Sci. 2000; 88(6): 640-650.
15. Turk M., Hils P., Helfgen B., Schaber K., Martin H. J., and Wahl M. A. Micronization of pharmaceutical substances by rapid expansion of supercritical solutions (RESS): A promising method to improve bioavailability of poorly soluble pharmaceutical agents. J. Supercrit. Fluids. 2002; 22(1): 75-84.
16. Dixon D. J., Johnston K. P., and Brodemier R. A. Polymeric materials formed by precipitation with a compresses fluid antisolvent. AICHE J. 1993; 39(1): 127-139.
17. Reverchon E. and Porta G. D. Production of antibiotic micro and nano-particles by supercritical antisolvent precipitation. Powder Technol. 1999; 106 (1-2): 23-29.
18. Douglas S. J., Davis S. S., and Illum L., Nanoparticles in Drug Delivery., CRC Critical Review Ther. Drug Carr. Syst., 1987; 3 (3): 233-261.
19. Gref R., Minamitake Y., Peracchia M. T., Trubetskoy V., Torchilin V. P., and Langer R. Science. 1994; 263:1600-1603.
20. Sestier C., Da-silva M. F., Sabolovic D., Roger J., and Pons J. N. Electrophoresis. 1998; 19(7):1220-1226.
21. Carstensen H., Muller B. W., and Mullerr R. H. A dsorption of ethoxylated surfactants on nanoparticles, I: characterization by hydrophobic interaction chromatography. Int J Pharm. 1991; 67: 29-37.
22. Scholes P. D., Coombes A. G. A., Illum L., Davis S. S., Watts J. F., Ustariz C., Vert M. and Davies M. C. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J. Controlled Release 1999; 59: 261.
23. Sarbak Z., Staczyk A., and Kramer-Wachowiak M. Characterisation of surface properties of various fly ashes. Powder Technology. 2004; 1 45(2): 82-87.
24. Sarmento B., Ferreira D., Veiga F., and Ribeiro A. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydrate Polymers. 2006; 66(1): 1-7.
25. Schmidt C. and Bodmeier R. Incorporation of polymeric nanoparticles into solid dosage forms. J Control Rel. 1999; 57(2): 115-125.
26. Kreuter J. Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 1983; 14: 43-58.
27. Kreuter J. Nanoparticle-based drug-delivery systems. J Control Rel. 1991; 16: 169-176.
28. Magenheim B., Levy M. Y., and Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriersultrafiltration technique at low pressure. Int J Pharm. 1993; 94: 115-123.
29. Santander-Ortega M. J., Jódar-Reyes A. B., Csaba N., Bastos-González D., and Ortega-Vinuesa J. L. Colloidal stability of Pluronic F68-coated PLGA nanoparticles: A variety of stabilisation mechanisms. Journal of Colloid and Interface Science. 2006; 302(2): 522-529.
30. Nanotechnologies: A prileminary risk analysis on the basis of a workshop, European community, 2004. http://www.europa.eu.int/comm/health
31. Hoet P. M. H., Bruske-Hohlfeld I. and Salata O. V. Nanoparticles - known. and unknown health risks. J. nanobiotecnol., 2004; 2: 12.
32. Lademann J., Weigmann H., Rickmeyer C., Barthelmes H., Schaefer H., Mueller G., and Sterry W. Penetration of Titanium Dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacology and Applied Skin Physiology 1999;12:247-256.
33. Jani P., Halbert G. W., Langridge J., and Florence A. T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol. 1989; 41(12): 809-812.
34. Jani P., Halbert G. W., Langridge J., and Florence A. T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990; 42(12): 821-826.
35. Lee K. P., Kelly D. P., O'Neal F. O., Stadler J. C., and Kennedy G. L. Jr. Lung response to ultrafine Kevlar aramid synthetic fibrils following 2-year inhalation exposure in rats. Fundam Appl Toxicol. 1988; 11(1): 1-20.